Inhibition of smooth muscle cell proliferation in vitro by leflunomide, a new immunosuppressant, is antagonized by uridine
- 30 September 1995
- journal article
- Published by Elsevier in Immunology Letters
- Vol. 47 (3), 171-174
- https://doi.org/10.1016/0165-2478(95)00074-5
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- TREATMENT WITH RAPAMYCIN AND MYCOPHENOLIC ACID REDUCES ARTERIAL INTIMAL THICKENING PRODUCED BY MECHANICAL INJURY AND ALLOWS ENDOTHELIAL REPLACEMENTTransplantation, 1995
- EFFECTS OF RAPAMYCIN ON GROWTH FACTOR-STIMULATED VASCULAR SMOOTH MUSCLE CELL DNA SYNTHESIS INHIBITION OF BASIC FIBROBLAST GROWTH FACTOR AND PLATELET-DERIVED GROWTH FACTOR ACTION AND ANTAGONISM OF RAPAMYCIN BY FK506Transplantation, 1995
- Newer immunosuppressive drugs in concordant xenografting-Transplantation of hamster heart to ratXenotransplantation, 1994
- LEFLUNOMIDE CONTROLS REJECTION IN HAMSTER TO RAT CARDIAC XENOGRAFTSTransplantation, 1994
- Inhibition of Interleukin 2 (IL-2)-stimulated tyrosine kinase activity by leflunomideInflammation Research, 1994
- Inhibition of the epidermal growth factor receptor tyrosine kinase activity by leflunomideFEBS Letters, 1993
- RAPAMYCIN INHIBITS ARTERIAL INTIMAL THICKENING CAUSED BY BOTH ALLOIMMUNE AND MECHANICAL INJURYTransplantation, 1993
- LEFLUNOMIDE, A NOVEL IMMUNOSUPPRESSIVE AGENTTransplantation, 1993
- Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejectionInflammation Research, 1991